Genentech and Tercica question | INSM Message Board Posts

Insmed Incorporated

  INSM website

INSM   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  42537 of 42643  at  12/6/2018 4:05:10 PM  by

iounuthing


 In response to msg 42536 by  insmhistorian
view thread

Re: Genentech and Tercica question


  In parallel, the companies announced that they have entered a license and development agreement in order to end the dispute, while Tercica and Genentech have waived the damages awarded by the jury in the US patent infringement litigation.===
 
 so Insmed at the time could not afford  to pay the $7.5 million and all the royalties
Genetech wanted so they entered a lisense agreement and after papers signed Insmed
says we will just give up on Iplex till  patent expiration which is supposed to  be DEC 18 2018 and not pay you nothing== to bad so many have suffered from this deal and how many  more diseases could have been found after all these years==
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 177
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...